Market Overview:
The global cardiac allografts market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to factors such as rising incidence of cardiovascular diseases, increasing number of organ transplantations, and technological advancements in cardiac allografts. Based on type, the global cardiac allografts market is segmented into pulmonary valve lobe and non-pulmonary valve lobe. The pulmonary valve lobe segment is expected to grow at a higher CAGR during the forecast period owing to its advantages over other types of valves available in the market. Based on application, the global cardiac allografts market is segmented into hospitals, clinics, and other applications. The hospitals segment accounted for the largest share of the global cardiac allografts market in 2017 and is projected to grow at a higher CAGR during the forecast period.
Product Definition:
A cardiac allograft is a human heart that has been transplanted into another person. The importance of cardiac allografts is that they can save the lives of people who have end-stage heart failure.
With Pulmonary Valve Lobe:
The pulmonary valve lobes are the structures that remain after the removal of a lung. They are used in cardiac allografts to help re-vascularize and re-pulmonaryize the organ. The growth factor for this market is increasing adoption of these devices as they have minimal side effects, high efficiency rate, and low risk of rejection.
Non Pulmonary Valve Lobe:
The non-pulmonary valve is a structure that helps in maintaining the pulmonary blood flow. It also prevents the backflow of blood from entering into the heart. The main function of this valve is to prevent regurgitation or inhaling air while lungs are inflated during expiration. This device is used as a part of cardiac allografts and consists of two valves, which are attached to either side of the heart via veins.
Application Insights:
Based on application, the global cardiac allografts market is segmented into hospital, clinic and others. The hospital segment dominated the overall market in terms of revenue in 2017. This can be attributed to a large patient base with multiple diseases that require heart transplantation as a treatment option. Furthermore, increasing number of hospitals offering cardiac transplantation services across the globe is also expected to contribute significantly towards revenue generation over the forecast period.
The other application segment includes private clinics and non-governmental organizations (NGOs). Cardiac allografts are used extensively by these institutions owing to their low cost compared to manufactured products such as bioprosthetic valves or artificial hearts which are used for similar purposes.
Regional Analysis:
North America dominated the global market in 2017 owing to a rise in the number of cardiac transplantation procedures and high acceptance of CABG surgeries. The U.S.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to factors such as increasing awareness about organ donation, growing medical tourism industry, improvement in healthcare infrastructure along with rising disposable income especially after economic reforms undertaken by various governments since 1990s.
Growth Factors:
- Increasing incidence of cardiovascular diseases (CVDs)
- Growing awareness about the benefits of cardiac allografts surgery
- Rising number of organ transplantations due to the increasing prevalence of organ failure
- Technological advancements in cardiac allograft surgery procedures
- Increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Cardiac Allografts Market Research Report
By Type
With Pulmonary Valve Lobe, Non Pulmonary Valve Lobe
By Application
Hospital, Clinic, Other
By Companies
CryoLife, Inc., LeMaitre Vascular, CareDx, LifeNet Health, Medtronic
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
211
Number of Tables & Figures
148
Customization Available
Yes, the report can be customized as per your need.
Global Cardiac Allografts Market Report Segments:
The global Cardiac Allografts market is segmented on the basis of:
Types
With Pulmonary Valve Lobe, Non Pulmonary Valve Lobe
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- CryoLife, Inc.
- LeMaitre Vascular
- CareDx
- LifeNet Health
- Medtronic
Highlights of The Cardiac Allografts Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- With Pulmonary Valve Lobe
- Non Pulmonary Valve Lobe
- By Application:
- Hospital
- Clinic
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cardiac Allografts Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cardiac allografts are a type of transplant that involves the use of a donor heart. A donated heart is removed from a deceased person and then cleaned and prepared for transplant. The donor heart is then placed into a recipient who has been prepped with antibiotics to prevent infection.
Some of the major players in the cardiac allografts market are CryoLife, Inc., LeMaitre Vascular, CareDx, LifeNet Health, Medtronic.
The cardiac allografts market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cardiac Allografts Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Cardiac Allografts Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Cardiac Allografts Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Cardiac Allografts Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Cardiac Allografts Market Size & Forecast, 2018-2028 4.5.1 Cardiac Allografts Market Size and Y-o-Y Growth 4.5.2 Cardiac Allografts Market Absolute $ Opportunity
Chapter 5 Global Cardiac Allografts Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Cardiac Allografts Market Size Forecast by Type
5.2.1 With Pulmonary Valve Lobe
5.2.2 Non Pulmonary Valve Lobe
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Cardiac Allografts Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Cardiac Allografts Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cardiac Allografts Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cardiac Allografts Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Cardiac Allografts Analysis and Forecast
9.1 Introduction
9.2 North America Cardiac Allografts Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Cardiac Allografts Market Size Forecast by Type
9.6.1 With Pulmonary Valve Lobe
9.6.2 Non Pulmonary Valve Lobe
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Cardiac Allografts Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Cardiac Allografts Analysis and Forecast
10.1 Introduction
10.2 Europe Cardiac Allografts Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Cardiac Allografts Market Size Forecast by Type
10.6.1 With Pulmonary Valve Lobe
10.6.2 Non Pulmonary Valve Lobe
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Cardiac Allografts Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Cardiac Allografts Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Cardiac Allografts Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Cardiac Allografts Market Size Forecast by Type
11.6.1 With Pulmonary Valve Lobe
11.6.2 Non Pulmonary Valve Lobe
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Cardiac Allografts Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Cardiac Allografts Analysis and Forecast
12.1 Introduction
12.2 Latin America Cardiac Allografts Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Cardiac Allografts Market Size Forecast by Type
12.6.1 With Pulmonary Valve Lobe
12.6.2 Non Pulmonary Valve Lobe
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Cardiac Allografts Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Cardiac Allografts Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Cardiac Allografts Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Cardiac Allografts Market Size Forecast by Type
13.6.1 With Pulmonary Valve Lobe
13.6.2 Non Pulmonary Valve Lobe
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Cardiac Allografts Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cardiac Allografts Market: Competitive Dashboard
14.2 Global Cardiac Allografts Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 CryoLife, Inc.
14.3.2 LeMaitre Vascular
14.3.3 CareDx
14.3.4 LifeNet Health
14.3.5 Medtronic